Kentucky Retirement Systems Insurance Trust Fund’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-691
Closed -$239K 499
2024
Q1
$239K Sell
691
-55
-7% -$18.1K 0.02% 497
2023
Q4
$241K Sell
746
-1
-0.1% -$313 0.02% 494
2023
Q3
$268K Sell
747
-19
-2% -$7.33K 0.02% 483
2023
Q2
$290K Hold
766
0.02% 480
2023
Q1
$367K Sell
766
-2
-0.3% -$936 0.03% 450
2022
Q4
$323K Hold
768
0.03% 458
2022
Q3
$320K Buy
768
+29
+4% +$14.5K 0.03% 453
2022
Q2
$366K Buy
739
+101
+16% +$52.6K 0.03% 440
2022
Q1
$359K Buy
638
+65
+11% +$39.2K 0.03% 445
2021
Q4
$433K Sell
573
-12
-2% -$8.98K 0.04% 399
2021
Q3
$436K Buy
585
+24
+4% +$18K 0.05% 381
2021
Q2
$361K Sell
561
-19
-3% -$11.6K 0.04% 412
2021
Q1
$331K Sell
580
-15
-3% -$8.88K 0.04% 431
2020
Q4
$347K Buy
595
+34
+6% +$19.4K 0.04% 399
2020
Q3
$289K Buy
561
+35
+7% +$17.7K 0.04% 385
2020
Q2
$237K Buy
+526
New +$232K 0.04% 398

Other funds holding BIO

Kentucky Retirement Systems Insurance Trust Fund's BIO Position: Q2 2024 in Review

Kentucky Retirement Systems Insurance Trust Fund sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2024, closing a stake of 691 shares — an estimated $239K sold.

Kentucky Retirement Systems Insurance Trust Fund first reported a position in BIO in Q2 2020 and held it in 16 quarters. The position peaked at $436K in Q3 2021. 440 funds tracked by Wall St. Rank hold BIO as of Q2 2024.

  • Kentucky Retirement Systems Insurance Trust Fund reported no remaining Bio-Rad Laboratories Class A position as of Q2 2024 after selling out during the quarter.
  • Kentucky Retirement Systems Insurance Trust Fund sold 691 Bio-Rad Laboratories Class A shares in Q2 2024, an estimated $239K.
  • Kentucky Retirement Systems Insurance Trust Fund first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 16 quarters.
  • Kentucky Retirement Systems Insurance Trust Fund's Bio-Rad Laboratories Class A position peaked at $436K in Q3 2021.
  • 440 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2024.

Based on Kentucky Retirement Systems Insurance Trust Fund's 13F filing for Q2 2024, filed 12 Aug 2024.